Advanced search
Publication Cover
Scandinavian Journal of Infectious Diseases Volume 35, 2003 - Issue 1
Submit an article Journal homepage
309
Views
49
CrossRef citations to date
0
Altmetric
Research Article

Ciprofloxacin for 2 or 4 Weeks in the Treatment of Febrile Urinary Tract Infection in Men: A Randomized Trial with a 1 Year Follow-up

PETER ULLERYD Department of Infectious Diseases Sahlgrenska University Hospital Göteborg
&
TORSTEN SANDBERG Department of Infectious Diseases Sahlgrenska University Hospital Göteborg
Pages 34-39 | Published online: 08 Jul 2009

References

  • Warren JW, Abrutyn E, Hebel JR, Johnson JR, Schaeffer AJ, Stamm WE. Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women. Clin Infect Dis 1999; 29: 745–58.
  • Norrby SR. Short-term treatment of uncomplicated lower urinary tract infections in women. Rev Infect Dis 1990; 12: 458–67.
  • Gleckman R, Crowley M, Natsios GA. Therapy of recurrent invasive urinary-tract infections of men. N Engl J Med 1979; 301: 878–80.
  • Smith JW, Jones SR, Reed WP, Tice AD, Deupree RH, Kaijser B. Recurrent urinary tract infections in men. Characteristics and response to therapy. Ann Intern Med 1979; 91: 544–8.
  • Sabbaj J, Hoagland VL, Cook T. Norfloxacin versus co-trimoxazole in the treatment of recurring urinary tract infections in men. Scand J Infect Dis 1986; 48 (Suppl): S48–53.
  • Meares EM, Stamey TA. Bacteriologic localization patterns in bacterial prostatitis and urethritis. Invest Urol 1968; 5: 492–518.
  • Lipsky BA. Urinary tract infections in men. Epidemiology, pathophysiology, diagnosis, and treatment. Ann Intern Med 1989; 110: 138–50.
  • Pfau A. The treatment of chronic bacterial prostatitis: principles and management. In: Weidner W, Madsen PO, Schiefer HG, eds. Prostatitis. Etiopathology, diagnosis, and therapy. Berlin: Springer, 1994: 158–74.
  • Ulleryd P, Zackrisson B, Aus G, Bergdahl S, Hugosson J, Sandberg T. Prostatic involvement in men with febrile urinary tract infection as measured by serum prostate-specific antigen and transrectal ultrasonography. BJU Int 1999; 84: 470–4.
  • Naber KG. The role of quinolones in the treatment of chronic bacterial prostatitis. In: Weidner W, Madsen PO, Schiefer HG, eds. Prostatitis. Etiopathology, diagnosis, and therapy. Berlin: Springer, 1994: 175–90.
  • Bjerklund Johansen TE, Grüneberg RN, Guibert J, Hofstetter A, Lobel B, Naber KG, et al. The role of antibiotics in the treatment of chronic prostatitis: a consensus statement. Eur Urol 1998; 34: 457–66.
  • Rubin RH, Shapiro ED, Andriole VT, Davis RJ, Stamm WE. Evaluation of new anti-infective drugs for the treatment of urinary tract infection. Clin Infect Dis 1992; 15 (Suppl): S216–27.
  • Olsson-Liljequist B, Larsson P, Walder M, Miörner H. Antimicrobial susceptibility testing in Sweden. III. Methodology for susceptibility testing. Scand J Infect Dis 1997; 105 (Suppl): S13–23.
  • Ørskov F, Ørskov I. Serotyping of Escherichia coli. In: Bergan T, ed. Methods in microbiology. London: Academic Press, 1984: 43–112.
  • Sandberg T, Englund G, Lincoln K, Nilsson LG. Randomised double-blind study of norfloxacin and cefadroxil in the treatment of acute pyelonephritis. Eur J Clin Microbiol Infect Dis 1990; 9: 317–23.
  • Cronberg S, Banke S, Bergman B, Boman H, Eilard T, Elbel E, et al. Fewer bacterial relapses after oral treatment with norfloxacin than with ceftibuten in acute pyelonephritis initially treated with intravenous cefuroxime. Scand J Infect Dis 2001; 33: 339–43.
  • Ulleryd P, Zackrisson B, Aus G, Bergdahl S, Hugosson J, Sandberg T. Selective urological evaluation in men with febrile urinary tract infection. BJU Int 2001; 88: 15–20.
  • Warren JW. Clinical presentations and epidemiology of urinary tract infections. In: Mobley HLT, Warren JW, eds. Urinary tract infections: molecular pathogenesis and clinical management. Washington, DC: ASM Press, 1996: 3–27.
  • Sandberg T, Stokland E, Brolin I, Lidin-Janson G, Svanborg-Eden C. Selective use of excretory urography in women with acute pyelonephritis. J Urol 1989; 141: 1290–4.
  • Kärkkäinen U-M, Ikäheimo R, Katila M-L, Siitonen A. Recurrence of urinary tract infections in adult patients with community-acquired pyelonephritis caused by E. coli: a 1-year follow-up. Scand J Infect Dis 2000; 32: 495–9.
  • Lipsky BA. Prostatitis and urinary tract infection in men: what’s new; what’s true? Am J Med 1999; 106: 327–34.
  • Nickel JC. Prostatitis. In: Mulholland SG, ed. Antibiotic therapy in urology. Philadelphia, PA: Lippincott-Raven, 1996: 57–69.
  • Choong S, Whitfield H. Biofilms and their role in infections in urology. BJU Int 2000; 86: 935–41.
  • Naber KG, Busch W, Focht J, German Prostatitis Study Group. Ciprofloxacin in the treatment of chronic bacterial prostatitis: a prospective, non-comparative multicentre clinical trial with long-term follow-up. Int J Antimicrob Ag 2000; 14: 143–9.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.